Camlin Fine Sciences Ltd. - Blends Business Provides Cushion Against Headwinds
The blends business of CFS Mexico and CFS North America demonstrated sustained traction during the quarter, helping the company partially offset...
119 Views
Camlin Fine Sciences Ltd - Price Slump Leads to Inventory Write-Offs
CFS North America topline grew to Rs. 255.2 cr in FY24 vs 85 Cr in FY23. Company expects CFS North America business to grow at ~25% in FY25.
172 Views
Camlin Fine Sciences Ltd - Key Product Prices Nose Dive; Blends Business Comes to Aid
CFS reported Q3 numbers that slightly beat our estimates due to inventory sales, and EBITDA missed our estimates due to certain one-off elements of...
260 Views
Camlin Fine Sciences Ltd. - Macro Headwinds Persist; Subsidiaries Show Good Growth
EBITDA declined significantly by 35% QoQ and missed our estimate by 46.5%. EBITDA Margin declined to 6.2% (from 11.4%/9.2% in Q2FY23/Q1FY24).
226 Views
Chemicals and Midcaps Q1FY25 Result Preview
Chemicals& Agrochemicals: In Q1FY25, we expect most of the specialty chemical companies under our coverage to show stronger performance compared to...
166 Views